Physician: CDC Opioid Prescribing Guidelines for Chronic Pain
40.00
Online
Elective
Please select your state to enroll in this course
About the Course:
Physicians, nurses, and other health care professionals must better understand their competing responsibilities related to the prescription of opioids and be able to effectively evaluate all patients for their level of risk for misuse or abuse of opioids. This course reviews the 2016 CDC guidelines for prescribing opioids to patients with chronic non-cancer pain. An expert panel formed to create guidelines for the use of opioids in the treatment of chronic, non-cancer pain concluded that adequate patient risk assessment and risk management for opioid abuse, addiction, and diversion is essential. 

Learning Objectives:
Completion of this course will better enable the course participant to:
  • Discuss the current scope of prescription opioid abuse, addiction, and overdose deaths.
  • Recognize recommended time frames for clinician evaluation of risks and benefits following initiation of an opioid prescription.
  • Describe the contrasting levels of evidence for the effectiveness of opioids for long-term treatment of chronic non-cancer pain and for the severity of the potential risks posed by such treatment.
  • Explain the value of function-based treatment goals as opposed to pain-relief goals.
  • Identify the 50 milligrams morphine equivalent/day (MMED) level that is recommended as a point to reassess benefits and risks of an opioid prescription.
  • Explain why special care must be taken with extended-release/long-acting (ER/LA) opioid formulations.
  • Discuss why methadone must be prescribed with particular caution.
  • Describe the recommendations about the prescription of opioid analgesics to pregnant women.
  • Identify the potential value of using PDMPs and the recommended frequency for consulting a PDMP for patients on long-term opioid therapy.
Accreditation Statement
InforMed is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Designation Statement
InforMed designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

CDC Opioid Prescribing Guidelines for Chronic Pain

40.00
About the Course:
Physicians, nurses, and other health care professionals must better understand their competing responsibilities related to the prescription of opioids and be able to effectively evaluate all patients for their level of risk for misuse or abuse of opioids. This course reviews the 2016 CDC guidelines for prescribing opioids to patients with chronic non-cancer pain. An expert panel formed to create guidelines for the use of opioids in the treatment of chronic, non-cancer pain concluded that adequate patient risk assessment and risk management for opioid abuse, addiction, and diversion is essential. 

Learning Objectives:
Completion of this course will better enable the course participant to:
  • Discuss the current scope of prescription opioid abuse, addiction, and overdose deaths.
  • Recognize recommended time frames for clinician evaluation of risks and benefits following initiation of an opioid prescription.
  • Describe the contrasting levels of evidence for the effectiveness of opioids for long-term treatment of chronic non-cancer pain and for the severity of the potential risks posed by such treatment.
  • Explain the value of function-based treatment goals as opposed to pain-relief goals.
  • Identify the 50 milligrams morphine equivalent/day (MMED) level that is recommended as a point to reassess benefits and risks of an opioid prescription.
  • Explain why special care must be taken with extended-release/long-acting (ER/LA) opioid formulations.
  • Discuss why methadone must be prescribed with particular caution.
  • Describe the recommendations about the prescription of opioid analgesics to pregnant women.
  • Identify the potential value of using PDMPs and the recommended frequency for consulting a PDMP for patients on long-term opioid therapy.
Accreditation Statement
InforMed is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Designation Statement
InforMed designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.